Entrada Therapeutics GAAP EPS of -$0.94 beats by $0.30, revenue of $1.3M misses by $6.11M
Source: SeekingAlpha
2026-02-26 07:44:19 ET
More on Entrada Therapeutics
- Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Entrada Therapeutics
- Historical earnings data for Entrada Therapeutics
- Financial information for Entrada Therapeutics
Read the full article on Seeking Alpha
For further details see:
Entrada Therapeutics GAAP EPS of -$0.94 beats by $0.30, revenue of $1.3M misses by $6.11M
Entrada Therapeutics Inc.
NASDAQ: TRDA
TRDA Trading
3.44% G/L:
$12.10 Last:
190,156 Volume:
$11.43 Open:
TRDA Latest News
February 26, 2026 07:00:00 am
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
TRDA Stock Data
$413,532,090
18,654,807
28.07%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
